ABSI Absci Corporation
Healthcare$5.28+3.53%ClosedMarket Cap: $823.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.54
P/S
433.07
EV/EBITDA
-6.85
DCF Value
$0.04
FCF Yield
-12.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1316.9%
Operating Margin
-7000.8%
Net Margin
-6450.8%
ROE
-63.6%
ROA
-60.6%
ROIC
-72.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $215.0K | -1168.8% | $-30.8M | $-29.6M | $— | — |
| Q4 null | $650.0K | -335.1% | $-36.1M | $-29.6M | $— | — |
| FY null | $2.8M | -319.4% | $-124.7M | $-115.2M | $— | — |
| Q3 null | $378.0K | 100.0% | $-30.2M | $-28.7M | $— | — |
| Q2 null | $593.0K | -3349.9% | $-31.4M | $-30.6M | $— | — |
| Q1 null | $1.2M | -1288.0% | $-27.7M | $-26.3M | $— | — |
| Q4 null | $665.0K | -2452.9% | $-29.8M | $-29.0M | $— | — |
| FY null | $4.5M | -1277.6% | $-108.9M | $-103.1M | $— | — |
| Q3 null | $1.7M | -97.2% | $-28.9M | $-27.4M | $— | — |
| Q2 null | $1.3M | -1101.7% | $-26.7M | $-24.8M | $— | — |
| Q1 null | $898.0K | -1262.6% | $-23.5M | $-22.0M | $— | — |
| Q4 2023 | $338.0K | -3382.0% | $-24.7M | $-23.5M | $-0.25 | — |